Evidence map›Paper›PMID 37951306›Full record

ArticleThe Journal of biological chemistry2023

Functional characterization of the CRY2 circadian clock component variant p.Ser420Phe revealed a new degradation pathway for CRY2.

Gizem Cagla Parlak, Ibrahim Baris, Seref Gul, Ibrahim Halil Kavakli

Open access · goldAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. A structural decryption of cryptochromes.Frontiers in chemistry · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Gizem Cagla ParlakDepartment of Molecular Biology and Genetics, Koc University, Istanbul, Turkiye.
Ibrahim BarisDepartment of Molecular Biology and Genetics, Koc University, Istanbul, Turkiye.
Seref GulInstitute of Life Sciences and Biotechnology, Bezmialem Vakif University, Beykoz, Turkiye.
Ibrahim Halil KavakliDepartment of Molecular Biology and Genetics, Koc University, Istanbul, Turkiye; Department of Chemical and Biological Engineering, Koc University, Istanbul, Turkiye. Electronic address: hkavakli@ku.edu.tr.
Koç University · TRBezmiâlem Vakıf Üniversitesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cryptochromes (CRYs) are essential components of the circadian clock, playing a pivotal role as transcriptional repressors. Despite their significance, the precise mechanisms underlying CRYs' involvement in the circadian clock remain incompletely understood. In this study, we identified a rare CRY2 variant, p.Ser420Phe, from the 1000 Genomes Project and Ensembl database that is located in the functionally important coiled-coil-like helix (CC-helix) region. Functional characterization of this variant at the cellular level revealed that p.Ser420Phe CRY2 had reduced repression activity on CLOCK:BMAL1-driven transcription due to its reduced affinity to the core clock protein PER2 and defective translocation into the nucleus. Intriguingly, the CRY2 variant exhibited an unexpected resistance to degradation via the canonical proteasomal pathway, primarily due to the loss of interactions with E3 ligases (FBXL3 and FBXL21), which suggests Ser-420 of CRY2 is required for the interaction with E3 ligases. Further studies revealed that wild-type and CRY2 variants are degraded by the lysosomal-mediated degradation pathway, a mechanism not previously associated with CRY2. Surprisingly, our complementation study with Cry1

Indexed as

Amino Acid SubstitutionCircadian ClocksCryptochromesAnimalsARNTL Transcription FactorsCell LineCircadian RhythmCLOCK ProteinsF-Box ProteinsFibroblastsHumansLysosomesMicePeriod Circadian ProteinsUbiquitin-Protein LigasesARNTL Transcription FactorsBMAL1 protein, humanCLOCK ProteinsCRY2 protein, humanCry2 protein, mouseCryptochromesF-Box ProteinsFBXL21P protein, humanFBXL3 protein, humanPER2 protein, humanPeriod Circadian ProteinsUbiquitin-Protein Ligasescircadian rhythmcryptochrome 2lysosomal degradation pathwayproteasomal degradation pathwaySNP

Identifiers

PMID37951306
PMCPMC10731238
OpenAlexW4388557706

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.